ATE486599T1 - Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür - Google Patents
Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafürInfo
- Publication number
- ATE486599T1 ATE486599T1 AT05751188T AT05751188T ATE486599T1 AT E486599 T1 ATE486599 T1 AT E486599T1 AT 05751188 T AT05751188 T AT 05751188T AT 05751188 T AT05751188 T AT 05751188T AT E486599 T1 ATE486599 T1 AT E486599T1
- Authority
- AT
- Austria
- Prior art keywords
- composition containing
- pharmaceutical composition
- amlodipinesilate
- production method
- lisinopril dihydrate
- Prior art date
Links
- 229960002394 lisinopril Drugs 0.000 title abstract 2
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 abstract 1
- 229950004221 besilate Drugs 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0401170A HUP0401170A2 (en) | 2004-06-10 | 2004-06-10 | Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for |
| PCT/HU2005/000064 WO2005120502A1 (en) | 2004-06-10 | 2005-06-09 | New pharmaceutical composition and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE486599T1 true ATE486599T1 (de) | 2010-11-15 |
Family
ID=89985289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05751188T ATE486599T1 (de) | 2004-06-10 | 2005-06-09 | Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1765342B9 (https=) |
| AT (1) | ATE486599T1 (https=) |
| CY (1) | CY1111484T1 (https=) |
| DE (1) | DE602005024554D1 (https=) |
| DK (1) | DK1765342T3 (https=) |
| EA (1) | EA010288B1 (https=) |
| ES (1) | ES2354618T3 (https=) |
| HR (1) | HRP20110034T1 (https=) |
| HU (2) | HUP0401170A2 (https=) |
| ME (1) | ME01935B (https=) |
| PL (1) | PL1765342T4 (https=) |
| PT (1) | PT1765342E (https=) |
| RS (1) | RS51677B (https=) |
| SI (1) | SI1765342T1 (https=) |
| WO (1) | WO2005120502A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2790817A1 (en) * | 2010-02-24 | 2011-09-01 | Sanofi-Aventis Deutschland Gmbh | Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| RU2483728C1 (ru) * | 2011-09-29 | 2013-06-10 | Общество с ограниченной ответственностью "Озон" | Комбинированное гипотензивное средство и способ его получения |
| PL227900B1 (pl) * | 2012-11-15 | 2018-01-31 | Adamed Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję |
| CN105194647A (zh) * | 2014-06-30 | 2015-12-30 | 南京瑞尔医药有限公司 | 一种含有赖诺普利和苯磺酸氨氯地平的药物组合物及其制备方法 |
| CN106333948A (zh) * | 2016-08-23 | 2017-01-18 | 成都尚药科技有限公司 | 含有苯磺酸氨氯地平和二水合赖诺普利的药物及制备方法 |
| WO2018200691A2 (en) | 2017-04-25 | 2018-11-01 | Proteus Digital Health, Inc. | Lisinopril compositions with an ingestible event marker |
| GB2595203A (en) | 2020-03-03 | 2021-11-24 | Alkaloid Ad Skopje | Formulation |
| CN119730841A (zh) * | 2022-09-07 | 2025-03-28 | 拉塞·凯那司特 | Api含量提高的氨氯地平的立即释放口服药物形式 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11500140A (ja) * | 1995-03-16 | 1999-01-06 | ファイザー・インコーポレーテッド | アムロジピン、アムロジピン塩、もしくはフェロジピンとａｃｅ阻害薬とを含有する組成物 |
| HUP0202416A3 (en) | 2002-07-24 | 2006-01-30 | Richter Gedeon Vegyeszet | Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders |
-
2004
- 2004-06-10 HU HU0401170A patent/HUP0401170A2/hu unknown
-
2005
- 2005-06-09 PL PL05751188.3T patent/PL1765342T4/pl unknown
- 2005-06-09 EP EP05751188A patent/EP1765342B9/en not_active Expired - Lifetime
- 2005-06-09 SI SI200531194T patent/SI1765342T1/sl unknown
- 2005-06-09 HU HUE05751188A patent/HUE009867T4/hu unknown
- 2005-06-09 RS RS20100496A patent/RS51677B/sr unknown
- 2005-06-09 HR HR20110034T patent/HRP20110034T1/hr unknown
- 2005-06-09 AT AT05751188T patent/ATE486599T1/de active
- 2005-06-09 ME MEP-2010-496A patent/ME01935B/me unknown
- 2005-06-09 WO PCT/HU2005/000064 patent/WO2005120502A1/en not_active Ceased
- 2005-06-09 ES ES05751188T patent/ES2354618T3/es not_active Expired - Lifetime
- 2005-06-09 DE DE602005024554T patent/DE602005024554D1/de not_active Expired - Lifetime
- 2005-06-09 PT PT05751188T patent/PT1765342E/pt unknown
- 2005-06-09 DK DK05751188.3T patent/DK1765342T3/da active
- 2005-06-09 EA EA200602187A patent/EA010288B1/ru unknown
-
2010
- 2010-12-30 CY CY20101101203T patent/CY1111484T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1765342B9 (en) | 2011-02-23 |
| DK1765342T3 (da) | 2011-01-24 |
| PT1765342E (pt) | 2010-12-20 |
| RS51677B (sr) | 2011-10-31 |
| ES2354618T3 (es) | 2011-03-16 |
| EP1765342A1 (en) | 2007-03-28 |
| SI1765342T1 (sl) | 2011-02-28 |
| EP1765342B1 (en) | 2010-11-03 |
| WO2005120502A1 (en) | 2005-12-22 |
| HUE009867T2 (https=) | 2011-05-30 |
| HUE009867T4 (hu) | 2022-01-28 |
| PL1765342T4 (pl) | 2022-11-07 |
| HU0401170D0 (en) | 2004-08-30 |
| EA010288B1 (ru) | 2008-08-29 |
| CY1111484T1 (el) | 2015-08-05 |
| HUP0401170A2 (en) | 2006-09-28 |
| ME01935B (me) | 2011-10-31 |
| DE602005024554D1 (de) | 2010-12-16 |
| PL1765342T3 (pl) | 2011-04-29 |
| HRP20110034T1 (hr) | 2011-02-28 |
| EA200602187A1 (ru) | 2007-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL158589A (en) | Carboxylic acid substituted oxazole derivatives, process for their manufacture, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment and prophylaxis of diseases which are modulated by ppar-alpha and -gamma activators | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| ATE411280T1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
| NO20092529L (no) | Substituerte 2,3-dihydroimidazo[1,2-c]kinazolinderivater som er anvendbare for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese | |
| BR0312000A (pt) | Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos | |
| BRPI0408439A (pt) | composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético | |
| EP1784388B8 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| CY1111484T1 (el) | Φαρμακευτικη συνθεση που περιεχει αμλοδιπινη βεσυλικη και λισινοπριλη διυδρικη και μεθοδος παρασκευης αυτης | |
| DE60211769D1 (de) | Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen | |
| MXPA02011389A (es) | Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y aplicacion. | |
| ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
| ATE480244T1 (de) | Neue, hyaluronsäure oder hyaluronsaure derivate und collagenase enthaltende pharmazeutische zusammensetzungen zur topischen behandlung von wunden, verbrennungen und geschwüren | |
| DE602004019528D1 (de) | Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
| DK1218401T3 (da) | 4-Benzylaminoquinolin-konjugat med galdesyre og deres heteroanaloger, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| WO2004093867A3 (en) | Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use | |
| TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| CA2534259A1 (en) | Glycyrrhizin high-concentration preparation | |
| WO2004093827A3 (en) | Phenolic acid salts of gabapentin in solid dosage forms and methods of use | |
| PT1432407E (pt) | Composicoes de lisinopril que possuem dcpd de particulas grandes | |
| ATE415151T1 (de) | Formulierung zur verzögerten freisetzung von valproinsäure und deren derivate | |
| WO2002030874A3 (en) | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1765342 Country of ref document: EP |